GlassScriptPhysician profile
Julie Davolio
NPI 1366550584
$7,341.04
in general payments reported to CMS, 2019-2025
40 companies · $647 in 2025
The $647 reported for 2025 was more than what 83% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $593 · 2020: $221 · 2021: $4,511 · 2022: $198 · 2023: $582 · 2024: $589 · 2025: $647.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,718 · Education: $99.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,718.13 |
| Education | $99.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $4,365.17 | 2021 | |
| Organon LLC | $496.08 | 2021-2025 | Nexplanon |
| Astellas Pharma US INC | $316.80 | 2019-2025 | Veozah, Myrbetriq |
| Pfizer INC. | $273.53 | 2019-2024 | |
| Abbvie INC. | $223.96 | 2019-2023 | Lo Loestrin Fe, Orilissa |
| Sumitomo Pharma America, INC. | $220.97 | 2023-2025 | Myfembree |
| Hologic Sales and Service, LLC | $151.02 | 2019-2023 | Novasure, Coolseal Generator, Acessa Provu System |
| Novo Nordisk INC | $144.31 | 2019-2020 | |
| Bayer Healthcare Pharmaceuticals INC. | $88.16 | 2019-2025 | |
| Therapeuticsmd, INC. | $83.89 | 2019-2021 | |
| Sage Therapeutics, LLC | $78.80 | 2024-2025 | Zurzuvae |
| Smith+Nephew, INC. | $69.13 | 2019 | |
| Mayne Pharma Commercial LLC | $64.64 | 2023-2025 | |
| Daiichi Sankyo INC. | $62.01 | 2019-2024 | Injectafer |
| Lupin INC. | $54.30 | 2019 |
Show all 40 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Julie Davolio listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.